145 related articles for article (PubMed ID: 32238696)
1. Pro-apoptotic functions of TRAF2 in p53-mediated apoptosis induced by cisplatin.
Tsuchida M; Yokosawa T; Noguchi T; Shimada T; Yamada M; Sekiguchi Y; Hirata Y; Matsuzawa A
J Toxicol Sci; 2020; 45(4):219-226. PubMed ID: 32238696
[TBL] [Abstract][Full Text] [Related]
2. Brefeldin A-Inhibited Guanine Nucleotide-Exchange Factor 1 (BIG1) Governs the Recruitment of Tumor Necrosis Factor Receptor-Associated Factor 2 (TRAF2) to Tumor Necrosis Factor Receptor 1 (TNFR1) Signaling Complexes.
Noguchi T; Tsuchida M; Kogue Y; Spadini C; Hirata Y; Matsuzawa A
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834853
[TBL] [Abstract][Full Text] [Related]
3. TRAF2 phosphorylation promotes NF-κB-dependent gene expression and inhibits oxidative stress-induced cell death.
Zhang L; Blackwell K; Altaeva A; Shi Z; Habelhah H
Mol Biol Cell; 2011 Jan; 22(1):128-40. PubMed ID: 21119000
[TBL] [Abstract][Full Text] [Related]
4. Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression.
Hu P; Han Z; Couvillon AD; Kaufman RJ; Exton JH
Mol Cell Biol; 2006 Apr; 26(8):3071-84. PubMed ID: 16581782
[TBL] [Abstract][Full Text] [Related]
5. TRAF2 phosphorylation modulates tumor necrosis factor alpha-induced gene expression and cell resistance to apoptosis.
Blackwell K; Zhang L; Thomas GS; Sun S; Nakano H; Habelhah H
Mol Cell Biol; 2009 Jan; 29(2):303-14. PubMed ID: 18981220
[TBL] [Abstract][Full Text] [Related]
6. TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling.
Kim YS; Nedospasov SA; Liu ZG
Mol Cell Biol; 2005 Mar; 25(6):2130-7. PubMed ID: 15743811
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
[TBL] [Abstract][Full Text] [Related]
8. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
Kanazawa K; Kudo A
J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
[TBL] [Abstract][Full Text] [Related]
9. Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell lines.
Sau A; Filomeni G; Pezzola S; D'Aguanno S; Tregno FP; Urbani A; Serra M; Pasello M; Picci P; Federici G; Caccuri AM
Mol Biosyst; 2012 Apr; 8(4):994-1006. PubMed ID: 22068640
[TBL] [Abstract][Full Text] [Related]
10. TRAF2 suppresses basal IKK activity in resting cells and TNFalpha can activate IKK in TRAF2 and TRAF5 double knockout cells.
Zhang L; Blackwell K; Thomas GS; Sun S; Yeh WC; Habelhah H
J Mol Biol; 2009 Jun; 389(3):495-510. PubMed ID: 19409903
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2.
Reinhard C; Shamoon B; Shyamala V; Williams LT
EMBO J; 1997 Mar; 16(5):1080-92. PubMed ID: 9118946
[TBL] [Abstract][Full Text] [Related]
12. HSP70 interacts with TRAF2 and differentially regulates TNFalpha signalling in human colon cancer cells.
Dai S; Jiang L; Wang G; Zhou X; Wei X; Cheng H; Wu Z; Wei D
J Cell Mol Med; 2010 Mar; 14(3):710-25. PubMed ID: 19243468
[TBL] [Abstract][Full Text] [Related]
13. TNF-α-mediated NF-κB survival signaling impairment by cisplatin enhances JNK activation allowing synergistic apoptosis of renal proximal tubular cells.
Benedetti G; Fredriksson L; Herpers B; Meerman J; van de Water B; de Graauw M
Biochem Pharmacol; 2013 Jan; 85(2):274-86. PubMed ID: 23103562
[TBL] [Abstract][Full Text] [Related]
14. Ultraviolet-irradiation-induced apoptosis is mediated via ligand independent activation of tumor necrosis factor receptor 1.
Sheikh MS; Antinore MJ; Huang Y; Fornace AJ
Oncogene; 1998 Nov; 17(20):2555-63. PubMed ID: 9840918
[TBL] [Abstract][Full Text] [Related]
15. Silibinin activated p53 and induced autophagic death in human fibrosarcoma HT1080 cells via reactive oxygen species-p38 and c-Jun N-terminal kinase pathways.
Duan WJ; Li QS; Xia MY; Tashiro S; Onodera S; Ikejima T
Biol Pharm Bull; 2011; 34(1):47-53. PubMed ID: 21212516
[TBL] [Abstract][Full Text] [Related]
16. TRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathways.
Zhang L; Dittmer MR; Blackwell K; Workman LM; Hostager B; Habelhah H
Cell Signal; 2015 Feb; 27(2):306-14. PubMed ID: 25446254
[TBL] [Abstract][Full Text] [Related]
17. Polyubiquitinated tristetraprolin protects from TNF-induced, caspase-mediated apoptosis.
Resch U; Cuapio A; Sturtzel C; Hofer E; de Martin R; Holper-Schichl YM
J Biol Chem; 2014 Sep; 289(36):25088-100. PubMed ID: 25056949
[TBL] [Abstract][Full Text] [Related]
18. JNK and p53 stress signaling cascades are altered in MCF-7 cells resistant to tumor necrosis factor-mediated apoptosis.
Doman RK; Perez M; Donato NJ
J Interferon Cytokine Res; 1999 Mar; 19(3):261-9. PubMed ID: 10213465
[TBL] [Abstract][Full Text] [Related]
19. TAp73-mediated the activation of c-Jun N-terminal kinase enhances cellular chemosensitivity to cisplatin in ovarian cancer cells.
Zhang P; Liu SS; Ngan HY
PLoS One; 2012; 7(8):e42985. PubMed ID: 22900074
[TBL] [Abstract][Full Text] [Related]
20. Jun kinase modulates tumor necrosis factor-dependent apoptosis in liver cells.
Liedtke C; Plümpe J; Kubicka S; Bradham CA; Manns MP; Brenner DA; Trautwein C
Hepatology; 2002 Aug; 36(2):315-25. PubMed ID: 12143039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
